Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions
Abstract There is growing evidence that Fusobacterium nucleatum, a Gram-negative anaerobic bacterium found in the gut and oropharynx, is a key player in the pathogenesis of colorectal cancer (CRC), by promoting tumor progression, immune evasion, and drug resistance. Despite the effectiveness of anti...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2025-10-01
|
| Reeks: | Infectious Agents and Cancer |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s13027-025-00676-w |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|